Waters Corporation introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARSCoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.
For biomedical and clinical research laboratories that are involved in fighting the pandemic, this kit offers a useful research tool for deeper study of the virus and the versatility to enable pioneering research of other infectious pathogens. The accelerated development of this method shows what's possible through collaboration and represents an important step towards equipping scientists around the world with a highly versatile, reproducible, and quantitative platform capable of providing new insights into this and future pandemics, said Dr Udit Batra, CEO and President, Waters Corporation.
Bu hikaye Express Pharma dergisinin July 2021 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Express Pharma dergisinin July 2021 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
SRICO: A trusted partner to enhance scientific research
Since 2011, SRICO has been a trusted provider of high-quality scientific instruments to diverse sectors, including pharmaceuticals, life sciences, and environmental science. With dedicated service centers and expert support teams across India, SRICO ensures tailored, compliant, and reliable solutions for research and production needs
Think global, act local - Romaco's approach to the Indian pharma market
The Indian pharmaceutical market is dynamic and increasingly international, which is reflected in trade fairs such as CPHI & PMEC India. Jens Torkel, MD, Romaco Group, a leading international supplier of machines and integrated system solutions for the development, manufacture and packaging of pharmaceuticals, and Sanjeev A. Nimkar, MD, Romaco India, Romaco's Sales & Service Centre based in Mumbai, underline the importance of the CPHI & PMEC and explain how machine manufacturers are meeting the requirements of pharma companies in India
Sigachi isn't just a supplier; we are a strategic partner
Amit Raj Sinha, MD and CEO, Sigachi explains that his company's strategic growth and diversification across excipients, APIs, food, nutrition, and personal care are driven by innovation, sustainability, and a customer-first approach. The company's focus on quality, regulatory compliance, and digital transformation positions it as a trusted global partner across industries
Driving pharma efficiency with Körber's Ecosystem solutions
Körber streamlines pharmaceutical manufacturing with a comprehensive ecosystem of advanced and connected solutions. Their guiding principle is simple: Everything, effortlessly, in one place. With top-tier solutions spanning cutting-edge machinery, packaging, materials, software, and expert guidance, Körber propels clients towards establishing their Factory of Excellence, optimizing every process for efficiency and safety, inform Rajesh Vedak President Körber India, Körber Business Area Pharma.
Customer satisfaction and innovation drive JULABO's growth in global temperature control markets
Markus Juchheim, Managing Director of JULABO GmbH, shares insights with Express Pharma on the company's strategies for innovation, regulatory compliance, and customer-focused growth in the evolving temperature control technology market.
From lab to plant: Process safety data sheets as the key to safe scale-up
Mario Toubes-Rodrigo, Global Applications Leader, H.E.L Group highlights that process safety testing is essential in API manufacturing to safely scale production from lab to industrial levels. Advanced techniques help identify and mitigate hazards, ensuring safe, compliant, and efficient processes
Eco-conscious packaging: A strategic opportunity
Larger pharma companies are applying sustainable practices and eco-conscious materials to packaging and labelling, leading to positive environmental outcomes, increasing operational efficiency and improving consumer perception. But wooing environmentally-conscious consumers often needs a sizeable capex, which could be a hurdle for pharma MSMEs. Viveka Roychowdhury reports that MSMEs can maximise this strategic opportunity once they identify areas which can improve efficiency through optimisation and harmonisation, at reasonable costs
ACG covers every facet of the pharma process, all under one roof and seamlessly interconnected
ACG Inspection's Life Sciences Cloud will be making its India debut at the CPhI India- PMec India 2024 show. Udit Singh, CEO, ACG Inspection spoke to Viveka Roychowdhury on its USPs, highlighting its modular nature, the zero cost of transition from existing systems, and the advantage of ACG's long term partnerships with global standard setting organisations like GS1 which allow its platforms to deliver regulatory compliance deliverables in advance
We, at OmniActive, invest over 10 per cent of the total outlay into R&D
Sanjaya Mariwala, Executive Chairman and MD, OmniActive Health Technologies shares insights into the company's significant investments in R&D, advanced testing capabilities, and strategies for optimising bioactive ingredients. He also discusses the impact of regulatory changes, quality assurance, and consumer education in the evolving nutraceutical landscape, in an interview with Viveka Roychowdhury
Save coating time, boost production efficiency
Instacoat 4G unique formulation includes an optimal ratio of polymer, plasticizer, and pigments, ensuring a smooth, uniform coating while significantly reducing preparation and process time
